The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

CNBC Published on Sep 7, 2016 Proove Biosciences has developed a series of medical tests that can show a doctor who is at a high risk for developing addiction to opioid painkillers. » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC About CNBC: From 'Wall...

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

PRConsultant Published on Feb 19, 2016 With prescription drug and heroin overdoses now killing more Americans than car accidents, the opioid crisis has worked its way into the speeches of presidential candidates and a billion dollar plan by President...

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree IRVINE, CA (PRWEB) October 24, 2013 Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and...

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

Proove Biosciences' Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...

April 21, 2014 – Issued by the American Academy of Neurology recognizing Proove’s quality research

Low Tolerance for Pain? The Reason May Be In Your Genes Apr 21, 2014, 15:15 ET from American Academy of Neurology ------------------------------------------------------------------------------------------------------- PHILADELPHIA, April 21,...

« Older Entries

April 19, 2017 – Proove Release: First Published Study of Precision Medicine to Predict Opioid Abuse

by admin | February 12, 2018 | Press Releases | 0 Comments

Results Published in the Journal Pharmacogenomics and Personalized Medicine Shows Proove Opioid Risk® Accurately Identifies Prescription Opioid Abuse Risk IRVINE, Calif., April 19, 2017 /PRNewswire/ -- As a Bronze Sponsor of the National Rx Drug Abuse and Heroin...

May 4, 2016 – Proove Release: Proove Announces Collaboration with McGill University

by admin | February 12, 2018 | In the News | 0 Comments

New Agreement Creates Collaborative Framework for Commercializing Laboratory Research to Help Pain Patients Irvine, CA (PRWEB) May 04, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce a strategic...

December 7, 2016 – Proove Release: Proove Launches First Precision Medicine Test for TMJ Disorder

by admin | February 12, 2018 | In the News | 0 Comments

Proove Launches the Only Commercially Available Genetic Analysis Offering Personalized Medical Treatment Recommendations for TMD Sufferers and Insights Into Contributing Causes of Orofacial Pain IRVINE, CA--(Marketwired - Dec 7, 2016) - Proove Biosciences, Inc., the...

April 13, 2016 – Proove Release: Proove and Insurer Specialty Health Announce Positive Coverage Determination for Genetic Testing

by admin | February 12, 2018 | In the News | 0 Comments

IRVINE, CA and RENO, NV (PRWEB) April 13, 2016 Proove Biosciences and Specialty Health are excited to announce a positive policy decision on the use of Proove Genetic testing to achieve the quadruple aim of improving outcomes, reducing costs, improving patient care,...

June 21, 2017 – Proove Release: Large Published Peer-Reviewed Clinical Utility Study Shows Pain Reduction

by admin | February 12, 2018 | Press Releases | 0 Comments

Study Shows Over 90% of Patients Experienced Significant Pain Reduction without Opioid Abuse and Physicians Believe Technology Provides Patient Benefits to Help Reduce Opioid Epidemic IRVINE, Calif., June 21, 2017 /PRNewswire/ -- Proove® Biosciences,...

May 2, 2017 – Proove Release: Proove CEO to Speak at 5 th Annual Medical Device Forum

by admin | February 12, 2018 | Press Releases | 0 Comments

Award-Winning Entrepreneur Brian Meshkin will speak at the 10X Medical Device Conference in San Diego IRVINE, Calif., May 2, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its founder and Chief Executive Officer, Brian Meshkin, will speak at the...

April 23, 2015 – Proove Release: Proove Biosciences Launches World's First Test To Predict Responders To Commonly Prescribed Non-Opioid Pain Medications

by admin | February 12, 2018 | In the News | 0 Comments

The new Proove Non-Opioid Pain Medication Response profile evaluates genetic factors to predict a patient’s response to non opioids before prescribing Irvine, CA (PRWEB) - Proove Biosciences, a commercial and research leader in Personalized Medicine, is excited to...

March 30, 2016 – Proove Release: Proove Expands Sales Force

by admin | February 12, 2018 | Press Releases | 0 Comments

IRVINE, CA (PRWEB) MARCH 30, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the expansion of its salesforce. Building on record growth, Proove Biosciences is expanding its network of authorized...

May 10, 2017 – Proove Release: Proove Publishes Another Study Validating 97% Accuracy of Opioid Risk Technology

by admin | February 12, 2018 | Press Releases | 0 Comments

Results Published in the Journal of Addiction Research and Therapy Shows Nearly 97% Accuracy in Identifying Patients At-Risk of Prescription Opioid Abuse IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces a new study validating the...

Get Instant Access to Updates to The Truth about Proove Bio

Success!

Last Name

The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

April 21, 2014 – Issued by the American Academy of Neurology recognizing Proove’s quality research

April 19, 2017 – Proove Release: First Published Study of Precision Medicine to Predict Opioid Abuse

May 4, 2016 – Proove Release: Proove Announces Collaboration with McGill University

December 7, 2016 – Proove Release: Proove Launches First Precision Medicine Test for TMJ Disorder

April 13, 2016 – Proove Release: Proove and Insurer Specialty Health Announce Positive Coverage Determination for Genetic Testing

June 21, 2017 – Proove Release: Large Published Peer-Reviewed Clinical Utility Study Shows Pain Reduction

May 2, 2017 – Proove Release: Proove CEO to Speak at 5 th Annual Medical Device Forum

April 23, 2015 – Proove Release: Proove Biosciences Launches World's First Test To Predict Responders To Commonly Prescribed Non-Opioid Pain Medications

March 30, 2016 – Proove Release: Proove Expands Sales Force

May 10, 2017 – Proove Release: Proove Publishes Another Study Validating 97% Accuracy of Opioid Risk Technology

April 21, 2014 – Issued by the American Academy of Neurology recognizing Proove’s quality research

Video’s

A medical test that aims to wean America off painkillers

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

OC Tech Alliance High Tech Innovation Awards 2015

SmartCEO Magazine Corporate Culture Awards in 2015

2016 Baltimore Future 50 Awards – Group 5

Get Instant Access to Updates to The Truth about Proove Bio

Success!